What is doxylamine, a first‑generation H1 antihistamine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Doxylamine?

Doxylamine is a first-generation H1 antihistamine that blocks histamine receptors and possesses significant sedative and anticholinergic properties, making it FDA-approved for use as a sleep aid and, in combination with pyridoxine (vitamin B6), as first-line pharmacologic treatment for nausea and vomiting of pregnancy. 1, 2

Pharmacologic Classification and Mechanism

Doxylamine functions as an H1-receptor inverse agonist, meaning it stabilizes the inactive conformation of H1-receptors and prevents histamine from binding 3. As a first-generation antihistamine, it readily crosses the blood-brain barrier, which accounts for its pronounced central nervous system effects 4.

Primary Clinical Uses

Sleep Aid

  • Available over-the-counter as 25 mg tablets 2
  • Dosed as one tablet 30 minutes before bedtime in adults and children ≥12 years 2
  • Used for occasional insomnia, with emerging evidence suggesting potential benefit for maintenance insomnia in the last third of the night 5

Nausea and Vomiting of Pregnancy (NVP)

  • FDA-approved and recommended by ACOG as first-line pharmacologic therapy for persistent NVP refractory to non-pharmacologic measures 1
  • Available in fixed-dose combinations with pyridoxine: 10 mg/10 mg and 20 mg/20 mg formulations 1
  • Safe and well-tolerated during pregnancy, with large epidemiological trials showing no teratogenic effects 6
  • Modified-release formulations provide sustained relief throughout the day and following morning 6, 7

Adverse Effects Profile

Central Nervous System Effects

Doxylamine shares the significant sedative burden characteristic of all first-generation antihistamines 4:

  • Drowsiness and performance impairment that can persist into the next day due to prolonged plasma half-lives 4
  • Performance impairment may occur without subjective awareness of drowsiness 4
  • Associated with 1.5-fold increased risk of fatal automobile accidents 4
  • Impaired work performance and increased occupational accidents 4
  • Risk of impaired learning and school performance in children 4

Anticholinergic Effects

  • Dry mouth and eyes
  • Constipation
  • Urinary retention
  • Increased risk of narrow-angle glaucoma provocation 4
  • Cognitive decline, particularly concerning in elderly patients 8

Special Populations at Higher Risk

Older adults warrant particular caution 4:

  • More sensitive to psychomotor impairment
  • Increased risk of falls leading to fractures and subdural hematomas
  • Greater susceptibility to anticholinergic effects
  • Comorbid conditions (increased intraocular pressure, benign prostatic hypertrophy, preexisting cognitive impairment) amplify risks

Overdose Considerations

  • Pediatric ingestions up to 6.2 mg/kg resulted only in transient drowsiness and tachycardia 9
  • Syndrome of inappropriate antidiuresis (SIAD) with severe hyponatremia reported in overdose 10
  • Abuse potential exists, with case reports of addiction at doses up to 125 mg/day 11

Critical Clinical Caveats

Drug Interactions

Concomitant use with other CNS-active substances significantly enhances impairment 4:

  • Alcohol
  • Sedatives and hypnotics
  • Antidepressants
  • Even cellular phone use worsens driving impairment 4

Comparison to Second-Generation Antihistamines

For allergic conditions, second-generation antihistamines (fexofenadine, loratadine, cetirizine) are strongly preferred over doxylamine due to 4:

  • Minimal to no sedation
  • No anticholinergic effects
  • No performance impairment
  • Better safety profile in all age groups

Bedtime Dosing Misconception

A common pitfall: dosing first-generation antihistamines only at bedtime does NOT avoid next-day impairment 4. The prolonged half-lives and persistent end-organ effects mean significant daytime drowsiness, decreased alertness, and performance impairment occur the following morning, often without the patient's awareness.

Appropriate Clinical Context

Doxylamine remains clinically appropriate in two specific scenarios:

  1. Pregnancy-related nausea and vomiting: As FDA-approved first-line pharmacologic therapy when combined with pyridoxine, after failure of dietary modifications 1

  2. Short-term sleep aid: For occasional insomnia in adults without contraindications, when the sedative effect is specifically desired 2

Before prescribing doxylamine, ensure patients understand both the potential for adverse effects and the availability of safer alternatives (particularly second-generation antihistamines for allergic conditions) 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.